XIAOMI-W
01810
POP MART
09992
BYD COMPANY
01211
4
MIXUE GROUP
02097
5
SMIC
00981
HK Stock MarketDetailed Quotes
01099 SINOPHARM
- 18.400
- +0.100+0.55%
Not Open May 9 16:08 CST
57.42BMarket Cap7.48P/E (TTM)
18.480High18.220Low3.94MVolume18.300Open18.300Pre Close72.52MTurnover0.29%Turnover Ratio7.54P/E (Static)3.12BShares23.65052wk High0.66P/B24.69BFloat Cap16.02052wk Low0.96Dividend TTM1.34BShs Float40.024Historical High0.956Dividend LFY1.42%Amplitude8.756Historical Low18.394Avg Price400Lot Size5.20%Div YieldTTM5.20%Div Yield LFY
SINOPHARM Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.81%141.66B | -2.02%584.51B | -0.78%442.42B | -2.07%294.73B | 1.20%147.27B | 8.05%596.57B | 9.73%445.92B | 15.10%300.95B | 14.04%145.52B | 5.97%552.15B |
| Operating income | -3.81%141.66B | -2.02%584.51B | -0.78%442.42B | -2.07%294.73B | 1.20%147.27B | 8.05%596.57B | 9.73%445.92B | 15.10%300.95B | 14.04%145.52B | 5.97%552.15B |
| Cost of sales | ---- | 1.42%-540.25B | ---- | 1.76%-272.78B | ---- | -8.59%-548.06B | ---- | -15.79%-277.68B | ---- | -5.81%-504.71B |
| Operating expenses | 3.59%-131.78B | 1.42%-540.25B | 0.34%-409.34B | 1.76%-272.78B | -1.57%-136.69B | -8.59%-548.06B | -10.31%-410.72B | -15.79%-277.68B | -14.45%-134.58B | -5.81%-504.71B |
| Gross profit | -6.55%9.88B | -8.77%44.26B | -5.99%33.09B | -5.70%21.94B | -3.34%10.58B | 2.27%48.51B | 3.38%35.2B | 7.45%23.27B | 9.30%10.94B | 7.68%47.43B |
| Selling expenses | 8.66%-3.84B | 1.79%-17.16B | -1.11%-12.79B | -0.54%-8.48B | -1.75%-4.21B | -4.50%-17.47B | -6.12%-12.65B | -8.44%-8.43B | -8.87%-4.13B | -8.30%-16.72B |
| Administrative expenses | 9.07%-1.59B | 3.05%-8.41B | 2.84%-5.33B | 1.33%-3.92B | -0.84%-1.75B | -6.04%-8.68B | -5.90%-5.48B | -8.43%-3.97B | -7.15%-1.74B | -5.44%-8.18B |
| Research and development expenses | 11.07%-63.26M | ---- | 24.99%-195.61M | ---- | 25.87%-71.13M | ---- | -23.96%-260.77M | ---- | -55.73%-95.96M | ---- |
| Profit from asset sales | 38.56%4.61M | 23.49%-1.58B | -96.73%10.53M | ---- | -85.73%3.33M | -6.80%-2.07B | 1,278.98%322.01M | ---- | 545.49%23.3M | -71.22%-1.94B |
| Revaluation surplus | -180.65%-16.85K | ---- | 3,176.15%3.16M | ---- | 135.67%20.9K | ---- | -101.34%-102.82K | ---- | -100.75%-58.58K | ---- |
| -Changes in the fair value of other assets | -180.65%-16.85K | ---- | 3,176.15%3.16M | ---- | 135.67%20.9K | ---- | -101.34%-102.82K | ---- | -100.75%-58.58K | ---- |
| Impairment and provision | -6.03%-955.91M | -107.11%-1.38B | -9.74%-1.78B | -1.98%-1.32B | -14.48%-901.55M | -0.07%-666.97M | -21.28%-1.62B | -30.58%-1.29B | -40.08%-787.55M | -11.36%-666.47M |
| -Other impairment is provision | -6.03%-955.91M | -107.11%-1.38B | -9.74%-1.78B | -1.98%-1.32B | -14.48%-901.55M | -0.07%-666.97M | -21.28%-1.62B | -30.58%-1.29B | -40.08%-787.55M | -11.36%-666.47M |
| Special items of operating profit | 28.00%272.82M | -19.48%468.62M | -29.40%405.75M | -768.52%-12.17M | -27.35%213.15M | -13.92%582.01M | 42.78%574.7M | 101.04%1.82M | 77.82%293.38M | 14.76%676.16M |
| Operating profit | -4.00%3.38B | -19.90%16.19B | -18.03%12.36B | -14.19%8.22B | -16.01%3.52B | -1.92%20.21B | 1.56%15.07B | 5.79%9.58B | 9.36%4.19B | 4.53%20.6B |
| Financing income | ---- | -17.00%616.97M | ---- | 11.17%389.45M | ---- | 36.96%743.37M | ---- | 9.77%350.3M | ---- | -2.83%542.77M |
| Financing cost | -4.64%-447.35M | 7.20%-2.95B | 25.05%-1.52B | 17.24%-1.46B | 23.68%-427.49M | 14.98%-3.17B | 10.00%-2.03B | 7.11%-1.77B | 18.79%-560.15M | 5.77%-3.73B |
| Share of profits of associates | ---- | 7.64%1.2B | ---- | 9.05%623.03M | ---- | 4.46%1.11B | ---- | 16.39%571.3M | ---- | -0.47%1.06B |
| Share of profit from joint venture company | ---- | 169.16%2.92M | ---- | -43.27%1.69M | ---- | -244.88%-4.22M | ---- | 46.72%2.98M | ---- | 318.99%2.91M |
| Special items of earning before tax | ---- | -269.12%-1.06B | ---- | -237.28%-176M | ---- | 660.80%625.97M | ---- | 236.55%128.2M | ---- | 121.89%82.28M |
| Adjustment items of earning before tax | -64.84%9.74M | ---- | 93.64%-1.24M | ---- | 635.15%27.71M | ---- | -2,740.26%-19.47M | ---- | -14.76%3.77M | ---- |
| Earning before tax | -5.73%2.94B | -28.25%14B | -16.82%10.84B | -14.32%7.6B | -14.15%3.12B | 5.11%19.51B | 3.47%13.03B | 10.77%8.87B | 15.49%3.64B | 9.18%18.56B |
| Tax | 5.04%-688.32M | 20.55%-3.58B | 17.35%-2.45B | 13.97%-1.7B | 12.44%-724.85M | -6.73%-4.5B | -6.55%-2.96B | -11.14%-1.97B | -14.72%-827.84M | -7.11%-4.22B |
| After-tax profit from continuing operations | -5.93%2.26B | -30.55%10.42B | -16.67%8.39B | -14.42%5.9B | -14.65%2.4B | 4.63%15.01B | 2.60%10.07B | 10.67%6.89B | 15.72%2.81B | 9.80%14.35B |
| Earning after tax | -5.93%2.26B | -30.55%10.42B | -16.67%8.39B | -14.42%5.9B | -14.65%2.4B | 4.63%15.01B | 2.60%10.07B | 10.67%6.89B | 15.72%2.81B | 9.80%14.35B |
| Minority profit | -18.32%798.98M | -43.35%3.37B | -21.67%3.11B | -21.28%2.2B | -19.80%978.14M | 2.34%5.96B | 0.39%3.97B | 10.02%2.79B | 21.91%1.22B | 9.68%5.82B |
| Profit attributable to shareholders | 2.59%1.46B | -22.14%7.05B | -13.41%5.28B | -9.76%3.7B | -10.70%1.42B | 6.19%9.05B | 4.09%6.1B | 11.12%4.1B | 11.38%1.59B | 9.89%8.53B |
| Basic earnings per share | 2.17%0.47 | -22.07%2.26 | -13.78%1.69 | -9.85%1.19 | -9.80%0.46 | 6.23%2.9 | 4.26%1.96 | 11.86%1.32 | 10.87%0.51 | 9.64%2.73 |
| Diluted earnings per share | 2.17%0.47 | -22.07%2.26 | -13.78%1.69 | -9.85%1.19 | -9.80%0.46 | 6.23%2.9 | 4.26%1.96 | 11.86%1.32 | 10.87%0.51 | 9.64%2.73 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Tianjian International Certified Public Accountants Limited, Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.